Novus Acquisition & Development Corp. (NDEV)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Novus Acquisition & Development Corp. (NDEV) trades at $0.02. Novus Acquisition & Development Corp. operates as an insurance company, focusing on health policies within the cannabis space. Market cap: $1.91M, Sector: Financial services.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for NDEV: NDEV does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NDEV against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
NDEV: 1/1 perspectives are bearish.
How is this calculated? →Novus Acquisition & Development Corp. (NDEV) Financial Services Profile
Novus Acquisition & Development Corp. is a financial services company providing health insurance policies, including specialized coverage for the cannabis industry, operating primarily in California. It distinguishes itself by offering niche health plans in the emerging cannabis market, alongside traditional benefit plans.
What Is the Investment Thesis for NDEV?
Novus Acquisition & Development Corp. presents a focused investment opportunity within the niche market of cannabis-related health insurance. With a P/E ratio of 11.09 and a profit margin of 46.8%, the company demonstrates profitability. Growth catalysts include the expansion of cannabis legalization across states and increasing acceptance of cannabis-related healthcare. The company's ability to maintain a competitive edge in this specialized market and scale its operations will be crucial for future growth. However, investors may want to evaluate the risks associated with regulatory changes and market volatility in the cannabis industry. Monitoring the company's ability to sustain its profit margins and expand its customer base is essential for evaluating its long-term investment potential.
Based on FMP financials and quantitative analysis
NDEV Key Highlights
- Operates as an insurance company through its subsidiary, WCIG Insurance Service, Inc.
- Specializes in health policies within the CBD concentrate cannabis space.
- Offers a range of benefit plans including dental, vision, hearing, and telemedicine.
- Profit Margin of 46.8% indicates strong profitability.
- P/E ratio of 11.09 suggests a potentially undervalued stock relative to its earnings.
Who Are NDEV's Competitors?
NDEV is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ADIA Adia Nutrition, Inc. | $0.12 | -22.08% | $11.33M | 48 |
| AEGOF Aegon N.V. | $8.39 | +0.00% | $12.62B | 66 |
| TLLXY Talanx AG | $60.33 | +0.00% | $31.16B | 64 |
| XZO Exzeo Group, Inc. | $18.71 | +0.11% | $1.70B | 64 |
| AIVAF Aviva plc | $8.45 | +0.00% | $25.28B | 64 |
| ACGL Arch Capital Group Ltd. | $101.64 | -0.55% | $35.51B | 47 |
| ABDBY Alm. Brand A/S | $5.00 | +0.00% | $3.42B | 47 |
| AGESF ageas SA/NV | $75.19 | +0.00% | $15.47B | 47 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NDEV's Key Strengths?
- Niche focus on the cannabis health insurance market.
- Established presence in California.
- High profit margin of 46.8%.
- Specialized knowledge of cannabis regulations.
What Are NDEV's Weaknesses?
- Limited geographic reach.
- Small market capitalization.
- Reliance on a single subsidiary.
- Vulnerability to regulatory changes.
What Could Drive NDEV Stock Higher?
- Expansion of cannabis legalization across the United States, creating new market opportunities.
- Increasing acceptance of cannabis-related healthcare, driving demand for specialized insurance products.
- Potential partnerships with cannabis companies to expand market reach.
- Development of new insurance products tailored to the cannabis industry.
- Investment in technology and digital marketing to improve customer acquisition and retention.
What Are the Key Risks for NDEV?
- Financial-distress signal — its Altman Z-Score of 1.59 sits in the distress zone (elevated bankruptcy risk).
- Regulatory changes in the cannabis industry could negatively impact the company's business.
- Increased competition from larger insurance companies entering the cannabis market.
- Economic downturn affecting insurance demand and customer affordability.
- Negative perception of the cannabis industry affecting customer adoption.
- Limited financial disclosure and low liquidity due to OTC listing.
What Are the Growth Opportunities for NDEV?
- Expansion into New Geographic Markets: As cannabis legalization expands across the United States and globally, Novus has the opportunity to enter new geographic markets. By securing licenses and partnerships in newly legalized states, Novus can extend its cannabis health insurance offerings to a broader customer base. The expansion into new markets could increase revenue by 20% within the next three years, contingent on regulatory approvals and market penetration.
- Development of New Insurance Products: Novus can develop new insurance products tailored to the specific needs of the cannabis industry, such as coverage for cannabis businesses, cultivators, and dispensaries. By diversifying its product offerings, Novus can attract a wider range of customers and increase its market share. The introduction of new insurance products could contribute to a 15% increase in revenue within the next two years, driven by increased customer acquisition and cross-selling opportunities.
- Strategic Partnerships with Cannabis Companies: Forming strategic partnerships with cannabis companies, such as cultivators, dispensaries, and manufacturers, can provide Novus with access to a captive customer base and enhance its market reach. By offering bundled insurance solutions to cannabis businesses, Novus can strengthen its competitive position and drive revenue growth. Strategic partnerships could lead to a 10% increase in revenue within the next year, driven by increased customer referrals and bundled service offerings.
- Increased Investment in Technology and Digital Marketing: Investing in technology and digital marketing can improve Novus's customer acquisition and retention efforts. By developing a user-friendly online platform and implementing targeted digital marketing campaigns, Novus can reach a wider audience and enhance its brand awareness. Increased investment in technology and digital marketing could result in a 25% increase in online sales and customer engagement within the next two years.
- Lobbying and Advocacy for Cannabis Insurance Regulations: Novus can actively participate in lobbying and advocacy efforts to promote the development of favorable cannabis insurance regulations. By working with policymakers and industry stakeholders, Novus can shape the regulatory landscape and create a more conducive environment for its business. Successful lobbying efforts could lead to increased market access and reduced regulatory barriers, contributing to long-term revenue growth and profitability.
What Opportunities Does NDEV Have?
- Expansion into new geographic markets.
- Development of new insurance products.
- Strategic partnerships with cannabis companies.
- Increased investment in technology and digital marketing.
What Threats Does NDEV Face?
- Regulatory changes in the cannabis industry.
- Increased competition from larger insurance companies.
- Economic downturn affecting insurance demand.
- Negative perception of the cannabis industry.
What Are NDEV's Competitive Advantages?
- Specialized focus on the cannabis health insurance market.
- Established presence in the California insurance market.
- Proprietary knowledge and expertise in cannabis insurance regulations.
- Strong relationships with cannabis industry stakeholders.
What Does NDEV Do?
Novus Acquisition & Development Corp., through its subsidiary WCIG Insurance Service, Inc., functions as an insurance provider based in California. Founded in 1996 and initially named BrandQuest Development Group, Inc., the company rebranded in April 2009 to reflect its focus on acquisition and development within the insurance sector. Novus specializes in offering health policies tailored to the CBD concentrate cannabis space, alongside a variety of benefit plans encompassing dental, vision, hearing, and telemedicine services. Additionally, the company provides THC health plans, catering to the evolving needs of the cannabis industry. Headquartered in Miami, Florida, Novus operates primarily within California's insurance market, targeting both individuals and businesses seeking specialized health coverage. The company's strategic focus on the cannabis industry positions it uniquely within the broader insurance landscape, allowing it to capitalize on the growing demand for cannabis-related health services and benefits. Novus aims to expand its market presence and product offerings to further penetrate the cannabis insurance sector.
What Products and Services Does NDEV Offer?
- Provides health insurance policies in the CBD concentrate cannabis space.
- Offers benefit plans including dental, vision, hearing, and telemedicine.
- Provides THC health plans.
- Operates through its subsidiary, WCIG Insurance Service, Inc.
- Focuses on the California insurance market.
- Targets individuals and businesses seeking specialized health coverage.
How Does NDEV Make Money?
- Generates revenue through the sale of health insurance policies.
- Earns premiums from policyholders.
- Focuses on specialized insurance products for the cannabis industry.
- Manages risk and claims through its insurance operations.
What Industry Does NDEV Operate In?
Novus Acquisition & Development Corp. operates within the diversified insurance industry, with a specific focus on the emerging cannabis health insurance market. The global insurance market is experiencing growth, driven by increasing healthcare costs and evolving regulatory landscapes. Novus distinguishes itself by targeting the cannabis industry, which is experiencing rapid growth and increasing demand for specialized insurance products. Competitors in the broader insurance market include companies like ADIA, AGSS, AVVH, IBKKF, and LFLS, but few directly focus on cannabis-related health insurance. This niche positioning offers both opportunities and challenges for Novus, requiring it to navigate regulatory complexities and establish a strong market presence.
Who Are NDEV's Key Customers?
- Individuals seeking health insurance coverage.
- Businesses in the cannabis industry.
- Individuals seeking specialized cannabis health plans.
- Companies offering employee benefits packages.
ROE 10%Key Financial Metrics
Return on equity for Novus Acquisition & Development Corp. stands at 10.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 10.0%, showing how much profit it generates from its asset base. NDEV trades at a trailing price-to-earnings ratio of 10.21, below the Financial Services sector average of ~18x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.43 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 9.8%, the inverse of the P/E and a quick read on earnings relative to price.
Novus Acquisition & Development Corp. (NDEV) Valuation Context
Valued at $1.91M, NDEV is classified as a micro-cap stock.
Company Profile
Novus Acquisition & Development Corp. operates in the Insurance - Diversified industry within the Financial Services sector. It is headquartered in Miami, US. The company is led by CEO Gary Frank Labrozzi. NDEV has traded publicly since 2013.
F-Score 4/9Financial Health
Novus Acquisition & Development Corp.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.59 places it in the distress zone, a signal of elevated financial risk.
NDEV Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Niche focus on the cannabis health insurance market.
- Established presence in California.
- High profit margin of 46.8%.
- Specialized knowledge of cannabis regulations.
Bear Case
- Limited geographic reach.
- Small market capitalization.
- Reliance on a single subsidiary.
- Vulnerability to regulatory changes.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
NDEV Latest News
No recent news available for NDEV.
NDEV Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NDEV.
Price Targets
Wall Street price target analysis for NDEV.
NDEV MoonshotScore
What does this score mean?
The MoonshotScore rates NDEV's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Gary Frank Labrozzi
CEO
Gary Frank Labrozzi serves as the CEO of Novus Acquisition & Development Corp. His professional background includes experience in the financial services and insurance industries. He has been involved in various aspects of business development, strategic planning, and operational management. Labrozzi's expertise lies in identifying growth opportunities and implementing strategies to enhance shareholder value. He has a track record of leading companies through periods of transformation and expansion. His leadership is focused on driving innovation and building a sustainable business model.
Track Record: Under Gary Frank Labrozzi's leadership, Novus Acquisition & Development Corp. has focused on specializing in the cannabis health insurance market. Key achievements include establishing a presence in California and developing specialized insurance products for the cannabis industry. Strategic decisions have centered on capitalizing on the growing demand for cannabis-related healthcare and navigating the evolving regulatory landscape. The company has achieved a high profit margin of 46.8% under his tenure.
NDEV OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Novus Acquisition & Development Corp. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not provide regular financial reporting, increasing the risk for investors. Unlike NYSE or NASDAQ listings, OTC Other stocks have less stringent listing requirements, potentially leading to greater price volatility and information asymmetry. This tier signifies a higher degree of risk and requires thorough due diligence before investment.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases information asymmetry.
- Low trading volume and liquidity can lead to price volatility.
- Higher risk of fraud or manipulation due to less regulatory oversight.
- Potential for delisting or trading suspension.
- OTC Other stocks may not be suitable for risk-averse investors.
- Verify the company's registration and legal standing.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Monitor trading volume and price volatility.
- Understand the risks associated with OTC investing.
- Consult with a financial advisor before investing.
- Operation through a subsidiary, WCIG Insurance Service, Inc.
- Focus on a specific niche market (cannabis health insurance).
- Company has been in operation since 1996.
- Headquartered in Miami, Florida.
Novus Acquisition & Development Corp. Financial Services Stock: Key Questions Answered
What does Novus Acquisition & Development Corp. do?
Novus Acquisition & Development Corp., through its subsidiary WCIG Insurance Service, Inc., operates as an insurance company specializing in health policies within the cannabis space. The company offers a range of benefit plans, including dental, vision, hearing, and telemedicine, as well as THC health plans. Novus focuses on providing specialized insurance products tailored to the unique needs of the cannabis industry, targeting both individuals and businesses seeking coverage in this emerging market. The company's business model centers on generating revenue through the sale of these specialized health insurance policies and managing risk through its insurance operations.
What are the main risks for NDEV?
The main risks for Novus Acquisition & Development Corp. include regulatory changes in the cannabis industry, which could impact the legality and marketability of its insurance products. Increased competition from larger insurance companies with greater resources poses a threat to Novus's market share. Economic downturns could reduce demand for insurance products and affect customer affordability. Negative perceptions of the cannabis industry could hinder customer adoption. Additionally, the company faces risks associated with its OTC listing, including limited financial disclosure, low liquidity, and potential for price volatility.
What are the key factors to evaluate for NDEV?
Evaluate NDEV on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does NDEV data refresh on this page?
NDEV prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven NDEV's recent stock price performance?
Novus Acquisition & Development Corp. (NDEV) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Niche focus on the cannabis health insurance market. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NDEV overvalued or undervalued right now?
Valuing Novus Acquisition & Development Corp. (NDEV) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying NDEV?
Before investing in Novus Acquisition & Development Corp. (NDEV), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding NDEV to a portfolio?
Key strength of Novus Acquisition & Development Corp. (NDEV): Niche focus on the cannabis health insurance market. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available for OTC-listed companies.
- AI analysis pending for NDEV.